IDH2 and neoplasm: This is clinically relevant, as it influences the likely value of IDH sequencing for a tumour which tests negative for an IDH1-R132H mutation but demonstrates imaging features suggestive of an IDH mutation, in particular T2-FLAIR mismatch.